135 related articles for article (PubMed ID: 19560191)
1. Racial disparities in survival among patients with germ cell tumors of the ovary--United States.
Bryant CS; Kumar S; Shah JP; Mahdi H; Ali-Fehmi R; Munkarah AR; Deppe G; Morris RT
Gynecol Oncol; 2009 Sep; 114(3):437-41. PubMed ID: 19560191
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in survival in malignant germ cell tumors of the ovary.
Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of laterality in malignant ovarian germ cell tumors.
Mahdi H; Kumar S; Seward S; Semaan A; Batchu R; Lockhart D; Tamimi H; Munkarah AR
Int J Gynecol Cancer; 2011 Feb; 21(2):257-62. PubMed ID: 21475076
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT
Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705
[TBL] [Abstract][Full Text] [Related]
5. Disparities in treatment and survival between African American and White women with vaginal cancer.
Mahdi H; Kumar S; Hanna RK; Munkarah AR; Lockhart D; Morris RT; Tamimi H; Swensen RE; Doherty M
Gynecol Oncol; 2011 Jul; 122(1):38-41. PubMed ID: 21497383
[TBL] [Abstract][Full Text] [Related]
6. Incidence and survival rates for female malignant germ cell tumors.
Smith HO; Berwick M; Verschraegen CF; Wiggins C; Lansing L; Muller CY; Qualls CR
Obstet Gynecol; 2006 May; 107(5):1075-85. PubMed ID: 16648414
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
Mahdi H; Swensen RE; Hanna R; Kumar S; Ali-Fehmi R; Semaan A; Tamimi H; Morris RT; Munkarah AR
Br J Cancer; 2011 Aug; 105(4):493-7. PubMed ID: 21772335
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
Sun M; Abdollah F; Liberman D; Abdo A; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Cancer; 2011 Sep; 117(18):4277-85. PubMed ID: 21387261
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
Chen Y; Ning Y; Zhang Q; Xie Y
Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
[TBL] [Abstract][Full Text] [Related]
10. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
11. Trends in the surgical management of malignant ovarian germcell tumors.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
[TBL] [Abstract][Full Text] [Related]
12. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.
Fuh KC; Shin JY; Kapp DS; Brooks RA; Ueda S; Urban RR; Chen LM; Chan JK
Gynecol Oncol; 2015 Mar; 136(3):491-7. PubMed ID: 25455734
[TBL] [Abstract][Full Text] [Related]
13. Racial disparity in 30-day morbidity and mortality after surgery for ovarian cancer.
Mahdi H; Jernigan A; Lockhart D; Moslemi-Kebria M; Rose PG
Int J Gynecol Cancer; 2015 Jan; 25(1):55-62. PubMed ID: 25427238
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.
Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566
[TBL] [Abstract][Full Text] [Related]
16. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
17. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
19. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
